Available Until 4/15/2025

It’s Ok to Not Be Ok: Ketamine and Esketamine for Treatment-Resistant Depression

ACPE Activity Number: 0204-0000-23-061-H01-P
Release Date: 04/15/2023
Expiration Date: 04/15/2025
Activity Type: Knowledge-based
CE Credits:  0.25 contact hour, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

Pharmacists providing care for patients with depression face countless treatment options. Many patients may not respond to traditional pharmacotherapy and cognitive behavioral therapy. As a result, many pharmacists are unaware of and do not practice according to the most current guidelines and literary evidence. With the most current information and effective practice strategies, pharmacists can improve their treatment of patients with neuropsychiatric needs.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These activities were planned to meet the educational needs of pharmacists involved in the management of patients with treatment resistant depression (TRD).  

After completing this activity, the learner should be able to…

  • Discuss the advantages and disadvantages of using ketamine and esketamine for depression.
  • Identify patients who are good candidates for ketamine and esketamine.
  • Describe dosing, routes of administration, and monitoring considerations for ketamine and esketamine.   

  • Introduction and Announcements 

  • Presentation  

Matthew A. Fuller, PharmD, FASHP, BCPP
National PBM Clinical Pharmacy Program Manager
Pharmacy Benefits Management Service

Bhavik M. Shah, PharmD, BCPS, BCIDP
Associate Professor
Jefferson College of Pharmacy
Philadelphia, PA 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.